Complete Filing Data
Replimune Group, Inc. reported Net Income Loss of -$247.30 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Replimune Group, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$247.3M | -$215.8M | -$174.3M | -$118.0M | -$80.9M | -$52.6M | -$30.8M | -$19.7M | -$7.7M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $174.0K | -$826.0K | $5.5M | $748.0K | $866.0K | -$236.0K | -$897.0K | $2.4M | -$1.4M |
| Operating Expenses | $261.6M | $234.8M | $177.1M | $118.3M | $80.0M | $56.2M | $30.9M | $19.2M | $9.6M |
| Research And Development Incentives Income | $1.8M | $1.9M | $2.9M | $3.2M | $2.8M | $3.1M | $2.5M | $2.3M | $1.4M |
| Research And Development Expense | $189.4M | $175.0M | $126.5M | $79.5M | $56.8M | $38.8M | $22.2M | $13.5M | $6.9M |
| Other Nonoperating Income Expense | -$202.0K | $771.0K | -$5.7M | -$1.1M | -$665.0K | -$16.0K | $451.0K | -$2.1M | $626.0K |
| Operating Income Loss | -$261.6M | -$234.8M | -$177.1M | -$118.3M | -$80.0M | -$56.2M | -$30.9M | -$19.2M | -$9.6M |
| Nonoperating Income Expense | $14.8M | $19.4M | $3.1M | $278.0K | -$915.0K | $3.6M | $112.0K | -$473.0K | $1.9M |
| Net Income Loss Available To Common Stockholders Basic | -$247.3M | -$215.8M | -$174.3M | -$118.0M | -$80.9M | -$52.6M | -$30.8M | -$19.7M | -$7.7M |
| General And Administrative Expense | $72.2M | $59.8M | $50.6M | $38.8M | $23.2M | $17.4M | $8.8M | $5.7M | $2.7M |
| Comprehensive Income Net Of Tax | -$246.7M | -$216.7M | -$167.6M | -$118.6M | -$80.3M | -$52.6M | -$31.7M | -$17.4M | -$9.1M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $419.0K | -$48.0K | $1.2M | -$1.3M | -$278.0K | $309.0K | |||
| Finance Lease Interest Expense | $2.1M | $2.2M | $2.2M | $2.2M | $2.2M | $1.2M | |||
| Research And Development Incentives Receivable Current | $4.9M | $2.9M | $3.1M | $3.0M | $3.0M | $2.5M | $2.4M | ||
| Interest Expense Debt | $5.8M | $4.5M | $2.0M | $0.00 | $818.0K | $734.0K | |||
| Other Comprehensive Income Loss Net Unrealized Gain Loss On Short Term Investments Net Of Tax | $309.0K | $80.0K | -$65.0K | ||||||
| Other Comprehensive Income Loss Available For Sale Securities Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$70.9M | -$83.1M | -$86.7M | -$66.3M | -$53.1M | -$53.8M | -$51.1M | -$60.0M | -$49.6M | -$39.7M | -$43.1M | -$42.3M | -$29.7M | -$29.4M | -$27.3M | -$21.5M | -$21.8M | -$20.1M | -$17.5M | -$15.8M | -$16.2M | -$11.1M | -$9.5M | -$6.7M | -$7.7M | -$6.5M | -$10.0M | -$7.1M | -$4.4M | -$4.7M | -$3.6M | |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $482.0K | $751.0K | -$938.0K | $3.1M | -$1.9M | -$432.0K | -$1.3M | $1.3M | -$1.3M | $158.0K | $2.3M | $1.7M | $161.0K | $219.0K | $224.0K | $548.0K | $626.0K | -$12.0K | $408.0K | -$218.0K | -$182.0K | -$102.0K | -$139.0K | -$847.0K | $111.0K | $624.0K | $953.0K | |||||
| Operating Expenses | $71.9M | $84.3M | $90.4M | $66.0M | $58.9M | $57.4M | $56.5M | $63.8M | $55.6M | $41.6M | $41.6M | $40.9M | $29.7M | $29.2M | $27.4M | $22.2M | $20.3M | $19.7M | $17.8M | $16.4M | $16.7M | $12.2M | $10.9M | $7.8M | $10.1M | $7.1M | $5.9M | $7.1M | $4.7M | $4.3M | $3.2M | |
| Research And Development Incentives Income | $341.0K | $377.0K | $420.0K | $376.0K | $408.0K | $438.0K | $415.0K | $443.0K | $393.0K | $607.0K | $574.0K | $851.0K | $733.0K | $725.0K | $788.0K | $550.0K | $755.0K | $686.0K | $951.0K | $620.0K | $621.0K | $1.6M | -$77.0K | $438.0K | $639.0K | $636.0K | $467.0K | |||||
| Research And Development Expense | $53.1M | $57.9M | $57.8M | $48.0M | $43.4M | $43.0M | $42.8M | $49.1M | $40.4M | $30.3M | $28.8M | $29.5M | $19.4M | $19.9M | $18.6M | $14.3M | $14.1M | $12.2M | $11.9M | $8.2M | $7.5M | $7.9M | $5.0M | $3.9M | $3.6M | $3.1M | $2.3M | |||||
| Other Nonoperating Income Expense | -$580.0K | -$876.0K | $591.0K | -$3.3M | $2.0M | $406.0K | $1.3M | -$1.4M | $1.4M | $147.0K | -$2.7M | -$2.0M | -$241.0K | -$356.0K | -$252.0K | -$454.0K | -$517.0K | -$28.0K | -$192.0K | $111.0K | $91.0K | $5.0K | $58.0K | $620.0K | $94.0K | -$472.0K | -$873.0K | |||||
| Operating Income Loss | -$71.9M | -$84.3M | -$90.4M | -$66.0M | -$58.9M | -$57.4M | -$56.5M | -$63.8M | -$55.6M | -$41.6M | -$41.6M | -$40.9M | -$29.7M | -$29.2M | -$27.4M | -$20.3M | -$19.7M | -$17.8M | -$16.7M | -$12.2M | -$10.9M | -$10.1M | -$7.1M | -$5.9M | -$4.7M | -$4.3M | -$3.2M | |||||
| Nonoperating Income Expense | $627.0K | $1.2M | $3.7M | $254.0K | $5.9M | $3.6M | $5.9M | $3.6M | $6.3M | $1.9M | -$1.5M | -$1.4M | $24.0K | -$108.0K | $70.0K | -$1.5M | -$432.0K | $340.0K | $475.0K | $1.1M | $1.4M | $2.5M | $643.0K | -$4.2M | $378.0K | -$404.0K | -$376.0K | |||||
| Net Income Loss Available To Common Stockholders Basic | -$70.9M | -$83.1M | -$86.7M | -$66.3M | -$53.1M | -$53.8M | -$51.1M | -$60.0M | -$49.6M | -$39.7M | -$43.1M | -$42.3M | -$29.7M | -$29.4M | -$27.3M | -$21.8M | -$20.1M | -$17.5M | -$16.2M | -$11.1M | -$9.5M | -$7.7M | -$6.5M | -$10.0M | -$4.4M | -$4.7M | -$3.6M | |||||
| General And Administrative Expense | $18.7M | $26.4M | $32.6M | $18.0M | $15.5M | $14.4M | $13.7M | $14.7M | $15.2M | $11.4M | $12.7M | $11.4M | $10.3M | $9.3M | $8.8M | $6.0M | $5.6M | $5.7M | $4.7M | $4.1M | $3.5M | $2.3M | $2.1M | $1.9M | $1.2M | $1.1M | $885.0K | |||||
| Comprehensive Income Net Of Tax | -$70.5M | -$82.2M | -$87.9M | -$63.8M | -$53.7M | -$54.3M | -$51.9M | -$58.5M | -$51.3M | -$38.9M | -$40.7M | -$40.8M | -$29.9M | -$29.1M | -$27.1M | -$21.3M | -$19.5M | -$17.7M | -$15.8M | -$11.4M | -$9.6M | -$7.8M | -$6.6M | -$10.9M | -$4.2M | -$4.0M | -$2.6M | |||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -$41.0K | $131.0K | -$269.0K | -$585.0K | $1.2M | -$99.0K | $534.0K | $214.0K | -$458.0K | $650.0K | $81.0K | -$244.0K | -$351.0K | $0.00 | -$40.0K | -$53.0K | -$47.0K | -$196.0K | ||||||||||||||
| Finance Lease Interest Expense | $514.0K | $518.0K | $521.0K | $528.0K | $531.0K | $534.0K | $540.0K | $542.0K | $544.0K | $548.0K | $550.0K | $552.0K | $555.0K | $557.0K | $558.0K | $560.0K | $562.0K | $561.0K | $834.0K | $195.0K | ||||||||||||
| Research And Development Incentives Receivable Current | $3.0M | $1.8M | $1.8M | $3.7M | $3.1M | $2.0M | $4.9M | $4.3M | $2.9M | $3.0M | $2.0M | $2.6M | $2.8M | $2.2M | $2.9M | $3.0M | $2.1M | $3.1M | $3.0M | $4.8M | $2.3M | $2.4M | $1.8M | $2.2M | ||||||||
| Interest Expense Debt | $1.5M | $1.5M | $1.5M | $1.5M | $1.4M | $1.4M | $1.0M | $955.0K | $1.1M | $941.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $247.0K | $286.0K | $284.0K | ||||||||||||||
| Other Comprehensive Income Loss Net Unrealized Gain Loss On Short Term Investments Net Of Tax | -$53.0K | -$47.0K | -$196.0K | -$25.0K | -$40.0K | $65.0K | -$55.0K | -$34.0K | $35.0K | -$5.0K | ||||||||||||||||||||||
| Other Comprehensive Income Loss Available For Sale Securities Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $555.3M | $411.2M | $498.7M | $183.7M | $137.9M | -$28.1M | -$11.5M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $148.2M | $107.6M | $184.2M | $61.1M | $26.9M | $17.7M | $20.7M | $14.4M | ||
| Short Term Investments | $346.2M | $436.8M | $289.7M | $293.8M | $109.1M | $109.1M | $44.0M | |||
| Retained Earnings Accumulated Deficit | -$701.3M | -$485.5M | -$311.2M | -$193.2M | -$112.3M | -$59.8M | -$28.9M | |||
| Restricted Cash Noncurrent | $1.7M | $1.6M | $1.6M | $1.6M | $1.6M | $1.2M | $78.0K | |||
| Property Plant And Equipment Net | $10.5M | $7.5M | $7.9M | $7.4M | $6.9M | $12.2M | $370.0K | |||
| Prepaid Expense And Other Assets Current | $8.1M | $6.3M | $5.3M | $4.5M | $2.7M | $3.7M | $763.0K | |||
| Liabilities Current | $40.4M | $33.8M | $20.8M | $14.5M | $11.9M | $9.9M | $5.2M | |||
| Liabilities And Stockholders Equity | $487.7M | $646.6M | $461.2M | $543.1M | $234.1M | $154.3M | $65.2M | |||
| Liabilities | $113.2M | $91.3M | $50.0M | $44.4M | $50.4M | $16.5M | $6.9M | |||
| Common Stock Value | $61.0K | $57.0K | $47.0K | $47.0K | $37.0K | $32.0K | $5.0K | |||
| Cash And Cash Equivalents At Carrying Value | $74.5M | $146.6M | $105.9M | $182.5M | $59.5M | $25.7M | $17.6M | |||
| Assets Current | $433.7M | $592.6M | $404.0M | $483.7M | $174.3M | $141.0M | $64.7M | |||
| Assets | $487.7M | $646.6M | $461.2M | $543.1M | $234.1M | $154.3M | $65.2M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $4.9M | $5.7M | -$973.0K | -$394.0K | -$982.0K | -$1.1M | -$238.0K | |||
| Accrued Liabilities And Other Liabilities | $34.0M | $24.7M | $13.4M | $8.7M | $5.2M | $2.8M | $3.2M | |||
| Accounts Payable Current | $2.6M | $5.4M | $3.7M | $2.4M | $3.4M | $7.1M | $2.0M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $36.7M | -$72.1M | $40.6M | -$76.6M | $123.0M | $34.2M | $9.2M | -$3.0M | $6.3M | |
| Net Amortization Of Premiums And Discounts On Short Term Investments | $8.9M | $12.3M | $5.6M | -$2.2M | -$1.4M | $945.0K | $1.7M | $123.0K | ||
| Operating Lease Right Of Use Asset | $4.6M | $5.2M | $5.6M | $400.0K | $4.4M | |||||
| Operating Lease Liability Noncurrent | $3.8M | $4.4M | $4.8M | $5.1M | $3.7M | |||||
| Finance Lease Liability Noncurrent | $23.4M | $24.0M | $24.4M | $24.7M | $25.0M | |||||
| Operating Lease Liability Current | $1.2M | $1.1M | $1.1M | $970.0K | $873.0K | |||||
| Finance Lease Right Of Use Asset | $37.2M | $39.7M | $42.1M | $44.5M | $46.9M | |||||
| Finance Lease Liability Current | $2.7M | $2.6M | $2.6M | $2.5M | $2.4M | |||||
| Finance Lease Principal Payments | $599.0K | $476.0K | $365.0K | $264.0K | $145.0K | $59.0K | ||||
| Increase Decrease Operating Lease Right Of Use Asset | -$683.0K | -$615.0K | -$225.0K | -$99.0K | -$447.0K | -$588.0K | ||||
| Increase Decrease Finance Lease Right Of Use Asset | -$2.4M | -$2.4M | -$2.4M | -$2.4M | -$2.4M | -$1.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q4 2017 | Q3 2017 | Q2 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $210.5M | $263.3M | $336.7M | $415.8M | $482.4M | $381.5M | $426.5M | $374.5M | $421.5M | $465.2M | $514.0M | $595.3M | $384.1M | $410.3M | $437.5M | $457.4M | $479.0M | $516.2M | $261.4M | $277.8M | $197.6M | $120.6M | $130.2M | $143.2M | $150.0M | -$38.7M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $124.7M | $104.0M | $99.1M | $112.8M | $173.9M | $115.2M | $153.4M | $76.2M | $99.3M | $77.6M | $108.1M | $208.3M | $90.6M | $113.9M | $133.9M | $161.6M | $194.2M | $326.1M | $45.0M | $106.4M | $64.6M | $64.6M | $40.0M | $22.2M | $24.5M | $14.8M | $39.2M | $67.7M | $16.0M | |
| Short Term Investments | $146.2M | $221.3M | $306.0M | $372.7M | $364.3M | $318.6M | $317.5M | $368.7M | $420.8M | $432.6M | $409.7M | $282.9M | $282.8M | $287.9M | $275.8M | $265.8M | $168.8M | $201.3M | $157.0M | $117.9M | $56.6M | $82.4M | $120.8M | $124.6M | $39.1M | |||||
| Retained Earnings Accumulated Deficit | -$1.19B | -$1.12B | -$1.04B | -$948.6M | -$874.4M | -$808.1M | -$755.1M | -$646.2M | -$595.1M | -$535.0M | -$436.2M | -$396.6M | -$353.5M | -$279.5M | -$249.8M | -$220.5M | -$171.7M | -$149.9M | -$129.8M | -$96.5M | -$80.3M | -$69.2M | -$53.1M | -$45.4M | -$39.0M | |||||
| Restricted Cash Noncurrent | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.2M | $1.2M | $1.9M | |||||
| Property Plant And Equipment Net | $13.8M | $14.7M | $14.7M | $13.7M | $13.6M | $12.6M | $11.4M | $9.5M | $8.4M | $7.6M | $7.7M | $7.9M | $8.3M | $7.4M | $7.2M | $7.2M | $7.2M | $7.2M | $7.4M | $5.7M | $3.5M | $963.0K | $6.1M | $420.0K | $443.0K | |||||
| Prepaid Expense And Other Assets Current | $8.3M | $8.3M | $8.2M | $8.4M | $8.0M | $8.5M | $6.3M | $8.5M | $8.5M | $7.9M | $5.6M | $5.0M | $4.0M | $5.4M | $5.7M | $3.3M | $4.0M | $4.7M | $3.0M | $5.2M | $5.8M | $4.5M | $1.3M | $1.8M | $944.0K | |||||
| Liabilities Current | $50.1M | $52.9M | $59.6M | $62.4M | $47.9M | $43.8M | $35.7M | $38.7M | $39.8M | $32.2M | $26.5M | $23.5M | $20.3M | $18.3M | $16.6M | $15.0M | $13.0M | $13.0M | $11.9M | $14.2M | $12.0M | $13.1M | $3.8M | $3.7M | $4.5M | |||||
| Liabilities And Stockholders Equity | $333.6M | $389.5M | $469.5M | $551.3M | $603.6M | $498.2M | $535.0M | $532.9M | $562.4M | $603.9M | $678.6M | $436.1M | $459.4M | $485.3M | $503.5M | $523.7M | $559.2M | $314.2M | $329.6M | $250.4M | $151.4M | $143.5M | $152.2M | $153.8M | $59.3M | |||||
| Liabilities | $123.1M | $126.1M | $132.8M | $135.5M | $121.3M | $116.7M | $108.5M | $111.4M | $97.2M | $89.9M | $83.2M | $52.0M | $49.2M | $47.8M | $46.1M | $44.7M | $43.0M | $52.9M | $51.8M | $52.9M | $30.8M | $13.4M | $8.9M | $3.8M | $11.6M | |||||
| Common Stock Value | $79.0K | $78.0K | $78.0K | $77.0K | $77.0K | $68.0K | $68.0K | $61.0K | $59.0K | $57.0K | $57.0K | $50.0K | $49.0K | $47.0K | $47.0K | $47.0K | $46.0K | $40.0K | $40.0K | $37.0K | $32.0K | $32.0K | $32.0K | $32.0K | $5.0K | |||||
| Cash And Cash Equivalents At Carrying Value | $123.0M | $102.3M | $97.4M | $111.1M | $172.2M | $113.5M | $151.7M | $97.7M | $76.0M | $106.5M | $206.7M | $88.9M | $112.2M | $132.3M | $160.0M | $192.5M | $324.5M | $43.3M | $104.8M | $63.0M | $53.3M | $38.4M | $21.1M | $23.3M | $12.9M | |||||
| Assets Current | $280.4M | $333.7M | $413.4M | $495.9M | $547.6M | $442.6M | $480.3M | $479.2M | $508.2M | $550.0M | $624.0M | $379.4M | $401.9M | $427.8M | $444.4M | $464.6M | $499.4M | $252.4M | $267.7M | $190.9M | $118.0M | $127.7M | $144.9M | $151.9M | $55.2M | |||||
| Assets | $333.6M | $389.5M | $469.5M | $551.3M | $603.6M | $498.2M | $535.0M | $532.9M | $562.4M | $603.9M | $678.6M | $436.1M | $459.4M | $485.3M | $503.5M | $523.7M | $559.2M | $314.2M | $329.6M | $250.4M | $151.4M | $143.5M | $152.2M | $153.8M | $59.3M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $5.6M | $5.1M | $4.2M | $5.4M | $6.2M | $3.6M | $4.3M | $4.7M | $5.5M | $4.0M | $3.7M | $2.9M | $520.0K | -$181.0K | $9.0K | -$210.0K | -$116.0K | -$611.0K | -$1.2M | -$1.0M | -$1.4M | -$1.2M | -$1.4M | -$1.2M | -$1.1M | |||||
| Accrued Liabilities And Other Liabilities | $40.4M | $42.4M | $40.0M | $45.9M | $36.8M | $31.4M | $30.9M | $30.9M | $31.7M | $23.6M | $19.2M | $15.9M | $12.2M | $10.8M | $10.0M | $9.2M | $7.2M | $7.2M | $5.1M | $4.6M | $3.4M | $1.8M | $2.3M | $1.7M | $1.6M | |||||
| Accounts Payable Current | $5.6M | $6.4M | $15.5M | $12.5M | $7.2M | $8.4M | $864.0K | $3.9M | $4.4M | $4.9M | $3.6M | $4.0M | $4.5M | $3.9M | $3.2M | $2.4M | $2.4M | $2.4M | $3.5M | $6.3M | $8.0M | $10.8M | $1.5M | $2.1M | $2.9M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$13.7M | $77.2M | -$40.1M | $6.3M | $10.0M | $45.3M | $13.1M | -$2.9M | ||||||||||||||||||||||
| Net Amortization Of Premiums And Discounts On Short Term Investments | $1.3M | $2.8M | $4.1M | -$243.0K | -$658.0K | -$91.0K | $436.0K | $121.0K | ||||||||||||||||||||||
| Operating Lease Right Of Use Asset | $3.5M | $3.7M | $3.9M | $4.0M | $4.1M | $4.4M | $4.5M | $4.8M | $4.9M | $5.1M | $5.0M | $5.0M | $5.3M | $5.7M | $5.5M | $5.7M | $5.8M | $5.8M | $5.9M | $4.7M | $4.9M | $4.4M | ||||||||
| Operating Lease Liability Noncurrent | $2.5M | $2.7M | $3.0M | $3.1M | $3.2M | $3.5M | $3.6M | $4.0M | $4.1M | $4.3M | $4.3M | $4.3M | $4.5M | $5.0M | $4.8M | $5.0M | $5.2M | $5.2M | $5.2M | $3.9M | $4.4M | $336.0K | $5.0M | |||||||
| Finance Lease Liability Noncurrent | $22.1M | $22.3M | $22.5M | $22.7M | $22.9M | $23.1M | $23.3M | $23.6M | $23.7M | $23.8M | $24.1M | $24.2M | $24.3M | $24.5M | $24.6M | $24.7M | $24.8M | $24.9M | $24.9M | $25.0M | $4.8M | $6.6M | ||||||||
| Operating Lease Liability Current | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.1M | $1.1M | $1.0M | $1.0M | $1.0M | $1.1M | $967.0K | $975.0K | $965.0K | $896.0K | $830.0K | $1.0M | $631.0K | $394.0K | ||||||||
| Finance Lease Right Of Use Asset | $33.0M | $33.6M | $34.2M | $34.8M | $35.4M | $36.0M | $36.6M | $37.8M | $38.5M | $39.1M | $40.3M | $40.9M | $41.5M | $42.7M | $43.3M | $43.9M | $45.1M | $45.7M | $46.3M | $47.5M | $7.1M | |||||||||
| Finance Lease Liability Current | $2.9M | $2.8M | $2.8M | $2.8M | $2.8M | $2.8M | $2.7M | $2.7M | $2.7M | $2.7M | $2.6M | $2.6M | $2.6M | $2.5M | $2.5M | $2.5M | $2.5M | $2.5M | $2.4M | $2.4M | $34.0K | |||||||||
| Finance Lease Principal Payments | $166.0K | $134.0K | $104.0K | $77.0K | $53.0K | $32.0K | $22.0K | |||||||||||||||||||||||
| Increase Decrease Operating Lease Right Of Use Asset | -$164.0K | -$148.0K | -$126.0K | -$108.0K | -$135.0K | -$85.0K | ||||||||||||||||||||||||
| Increase Decrease Finance Lease Right Of Use Asset | -$607.0K | -$607.0K | -$607.0K | -$607.0K | -$607.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $3.5M | $2.7M | $2.4M | $2.1M | $1.7M | $533.0K | $148.0K | $109.0K | $122.0K |
| Share Based Compensation | $35.0M | $34.1M | $28.1M | $24.3M | $11.8M | $7.7M | $2.7M | $812.0K | $208.0K |
| Net Cash Provided By Used In Operating Activities | -$192.3M | -$185.5M | -$128.1M | -$82.2M | -$61.4M | -$60.6M | -$25.4M | -$16.0M | -$7.1M |
| Net Cash Provided By Used In Investing Activities | -$23.8M | $97.2M | -$142.5M | -$1.8M | -$188.8M | -$5.2M | -$65.9M | -$44.0M | -$238.0K |
| Increase Decrease In Research And Development Incentives Receivable | -$1.3M | $1.9M | $61.0K | $247.0K | -$325.0K | $628.0K | $255.0K | $767.0K | $1.2M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $252.0K | $1.8M | $1.1M | $815.0K | $1.7M | -$933.0K | $801.0K | $305.0K | $325.0K |
| Increase Decrease In Accrued Expenses And Other Current Liabilities | $11.7M | $9.2M | $11.4M | $4.7M | $3.4M | $2.5M | -$292.0K | $1.4M | $1.4M |
| Increase Decrease In Accounts Payable | $9.9M | -$2.8M | $2.0M | $1.1M | -$1.0M | -$3.8M | $120.0K | $1.6M | $203.0K |
| Net Cash Provided By Used In Financing Activities | $252.4M | $16.3M | $311.3M | $6.6M | $372.5M | $100.2M | $101.4M | $54.8M | $15.0M |
| Payments To Acquire Short Term Investments | $403.6M | $489.5M | $583.4M | $255.7M | $392.4M | $149.7M | $189.9M | $52.5M | |
| Proceeds From Sale Maturity And Collection Of Shortterm Investments | $386.5M | $592.4M | $443.2M | $256.3M | $206.1M | $151.0M | $126.6M | $8.6M | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $315.0K | -$86.0K | -$109.0K | $818.0K | $721.0K | -$135.0K | -$839.0K | $2.3M | -$1.4M |
| Proceeds From Stock Options Exercised | $267.0K | $1.8M | $3.4M | $6.9M | $5.7M | $551.0K | $206.0K | ||
| Proceeds From Issuance Of Common Stock | $155.7M | $0.00 | $149.9M | $242.6M | $286.1M | $270.0M | $85.6M | ||
| Payments To Acquire Property Plant And Equipment | $2.3M | $2.3M | $2.4M | $6.5M | $2.6M | $136.0K | $238.0K | ||
| Increase Decrease In Operating Lease Liability | -$720.0K | -$620.0K | -$238.0K | -$73.0K | -$340.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q2 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q4 2017 | Q3 2017 | Q2 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $800.0K | $800.0K | $873.0K | $1.0M | $900.0K | $736.0K | $700.0K | $700.0K | $621.0K | $620.0K | $518.0K | $402.0K | $425.0K | $391.0K | $107.0K | $42.0K | $42.0K | $37.0K | $36.0K | $33.0K | $31.0K | $27.0K | $23.0K | ||
| Share Based Compensation | $8.8M | $9.5M | $8.8M | $7.2M | $6.3M | $3.0M | $2.8M | $2.5M | $2.3M | $1.8M | $1.8M | $880.0K | $718.0K | $225.0K | $45.0K | ||||||||||
| Net Cash Provided By Used In Operating Activities | -$77.0M | -$49.2M | -$48.6M | -$33.5M | -$18.3M | -$15.1M | -$13.6M | -$6.9M | -$5.5M | ||||||||||||||||
| Net Cash Provided By Used In Investing Activities | $65.0M | $29.8M | $7.4M | $5.3M | $27.0M | -$49.1M | $26.8M | $4.9M | -$33.0K | ||||||||||||||||
| Increase Decrease In Research And Development Incentives Receivable | -$1.6M | $437.0K | $393.0K | $850.0K | $788.0K | $684.0K | $621.0K | $438.0K | $468.0K | ||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$234.0K | -$1.8M | $1.6M | -$1.2M | -$1.2M | $301.0K | $847.0K | $220.0K | $1.3M | ||||||||||||||||
| Increase Decrease In Accrued Expenses And Other Current Liabilities | -$5.5M | -$3.2M | -$1.2M | -$1.1M | $456.0K | -$11.0K | -$885.0K | -$1.5M | -$660.0K | ||||||||||||||||
| Increase Decrease In Accounts Payable | $3.8M | -$1.6M | -$816.0K | $895.0K | $66.0K | -$224.0K | $3.8M | -$259.0K | $381.0K | ||||||||||||||||
| Net Cash Provided By Used In Financing Activities | -$158.0K | $96.6M | $1.1M | $32.5M | $1.1M | $109.5M | $18.0K | -$195.0K | |||||||||||||||||
| Payments To Acquire Short Term Investments | $37.6M | $105.5M | $169.3M | $60.6M | $32.2M | $125.8M | $18.5M | $10.7M | |||||||||||||||||
| Proceeds From Sale Maturity And Collection Of Shortterm Investments | $105.4M | $136.9M | $177.1M | $67.0M | $59.5M | $77.6M | $45.7M | $15.8M | |||||||||||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$1.6M | -$35.0K | $13.0K | $1.9M | $212.0K | -$1.0K | -$137.0K | -$731.0K | |||||||||||||||||
| Proceeds From Stock Options Exercised | $8.0K | $67.0K | $1.2M | $1.6M | $1.2M | $1.5M | $18.0K | ||||||||||||||||||
| Proceeds From Issuance Of Common Stock | $0.00 | $48.2M | $0.00 | $6.7M | $6.7M | $31.0M | $0.00 | ||||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $449.0K | $1.1M | $291.0K | $932.0K | $362.0K | $116.0K | $33.0K | ||||||||||||||||||
| Increase Decrease In Operating Lease Liability | -$195.0K | -$171.0K | -$153.0K | -$128.0K | -$106.0K | -$132.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$3.07 | -$3.24 | -$2.99 | -$2.26 | -$1.75 | -$1.54 | -$1.33 | -$3.96 | -$1.55 |
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 27.3M | ||
| Common Stock Shares Outstanding | 61.4M | 56.7M | 47.3M | 46.6M | 36.7M | 31.7M | 5.0M | ||
| Common Stock Shares Issued | 61.4M | 56.7M | 47.3M | 46.6M | 36.7M | 31.7M | 5.0M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Weighted Average Number Of Shares Outstanding Basic | 80.6M | 66.6M | 58.2M | 52.2M | 46.2M | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 80.6M | 66.6M | 58.2M | 52.2M | 46.2M | ||||
| Earnings Per Share Basic | $-3.07 | $-3.24 | $-2.99 | $-2.26 | $-1.75 | ||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 46.2M | 34.3M | 23.2M | 5.0M | 5.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.77 | -$0.90 | -$0.95 | -$0.79 | -$0.68 | -$0.78 | -$0.77 | -$0.90 | -$0.75 | -$0.69 | -$0.79 | -$0.78 | -$0.57 | -$0.56 | -$0.53 | -$0.42 | -$0.44 | -$0.46 | -$0.44 | -$0.41 | -$0.46 | -$0.35 | -$0.30 | -$0.29 | -$0.24 | -$0.26 | -$2.02 | -$1.43 | -$0.87 | -$0.94 | -$0.71 | |
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | ||||||||
| Common Stock Shares Outstanding | 79.6M | 78.4M | 77.8M | 77.1M | 77.0M | 68.4M | 68.3M | 61.4M | 59.1M | 59.0M | 56.6M | 49.7M | 49.3M | 47.2M | 46.9M | 46.7M | 46.4M | 40.3M | 40.3M | 36.6M | 31.7M | 31.7M | 31.6M | 31.6M | 5.0M | |||||||
| Common Stock Shares Issued | 79.6M | 78.4M | 77.8M | 77.1M | 77.0M | 68.4M | 68.3M | 61.4M | 59.1M | 59.0M | 56.6M | 49.7M | 49.3M | 47.2M | 46.9M | 46.7M | 46.4M | 40.3M | 40.3M | 36.6M | 31.7M | 31.7M | 31.6M | 31.6M | 5.0M | |||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Weighted Average Number Of Shares Outstanding Basic | 92.2M | 91.9M | 91.5M | 83.5M | 78.6M | 69.2M | 66.6M | 66.6M | 66.4M | 57.9M | 54.8M | 54.2M | 52.3M | 52.1M | 51.9M | 49.4M | 44.0M | 39.9M | ||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 92.2M | 91.9M | 91.5M | 83.5M | 78.6M | 69.2M | 66.6M | 66.6M | 66.4M | 57.9M | 54.8M | 54.2M | 52.3M | 52.1M | 51.9M | 49.4M | 44.0M | 39.9M | ||||||||||||||
| Earnings Per Share Basic | $-0.77 | $-0.90 | $-0.95 | $-0.79 | $-0.68 | $-0.78 | $-0.77 | $-0.90 | $-0.75 | $-0.69 | $-0.79 | $-0.78 | $-0.57 | $-0.56 | $-0.53 | $-0.44 | $-0.46 | $-0.44 | ||||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 49.4M | 44.0M | 39.9M | 34.9M | 31.7M | 31.7M | 31.6M | 24.6M | 5.0M | 5.0M | 5.0M | 5.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $35.0M | $34.1M | $28.1M | $24.3M | $11.8M | $7.7M | $2.7M | $812.0K | |
| Stock Issued During Period Value Stock Options Exercised | $267.0K | $1.8M | $3.4M | $6.9M | $5.7M | $551.0K | $206.0K | ||
| Investment Income Interest And Dividend | $21.1M | $23.4M | $10.0M | $390.0K | $916.0K | $2.4M | $2.6M | $288.0K | $25.0K |
| Additional Paid In Capital | $1.07B | $1.03B | $723.4M | $692.2M | $297.0M | $198.6M | $1.1M | ||
| Capital Expenditures Incurred But Not Yet Paid | $171.0K | $101.0K | $103.0K | $415.0K | $98.0K | $209.0K | $5.0M | ||
| Interest Paid Net | $4.2M | $3.0M | $1.1M | $0.00 | $636.0K | $578.0K | |||
| Stock Issued During Period Value New Issues | $149.9M | $286.1M | $101.2M | ||||||
| Paid In Kind Interest | $1.6M | $1.2M | $494.0K | $0.00 | $181.0K | $156.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q4 2018 | Q3 2018 | Q2 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $7.0M | $8.3M | $8.8M | $8.6M | $8.7M | $9.5M | $8.2M | $9.1M | $8.8M | $7.0M | $7.0M | $7.2M | $5.9M | $6.3M | $6.3M | $3.0M | $2.8M | $2.5M | $2.3M | $1.8M | $1.8M | $880.0K | $718.0K | $225.0K | |
| Stock Issued During Period Value Stock Options Exercised | $281.0K | $8.0K | $66.0K | $103.0K | $66.0K | $550.0K | $1.2M | $500.0K | $1.1M | $1.6M | $4.0M | $1.2M | $1.2M | $3.1M | $291.0K | $1.5M | $357.0K | $105.0K | $18.0K | $153.0K | $12.0K | ||||
| Investment Income Interest And Dividend | $2.8M | $3.7M | $4.7M | $5.1M | $5.4M | $4.7M | $5.7M | $6.0M | $6.2M | $2.7M | $1.1M | $343.0K | $87.0K | $80.0K | $92.0K | $116.0K | $178.0K | $527.0K | $550.0K | $567.0K | $687.0K | $882.0K | $664.0K | $227.0K | |
| Additional Paid In Capital | $1.39B | $1.38B | $1.37B | $1.36B | $1.35B | $1.19B | $1.18B | $1.06B | $1.05B | $1.05B | $1.03B | $777.7M | $763.2M | $717.2M | $707.2M | $699.7M | $687.9M | $411.8M | $408.8M | $295.1M | $202.4M | $200.5M | $197.7M | $196.7M | $1.3M |
| Capital Expenditures Incurred But Not Yet Paid | $645.0K | $87.0K | $412.0K | $318.0K | $39.0K | $64.0K | $21.0K | ||||||||||||||||||
| Interest Paid Net | $1.1M | $1.1M | $653.0K | $0.00 | $0.00 | $221.0K | |||||||||||||||||||
| Stock Issued During Period Value New Issues | $10.4M | $107.5M | $48.2M | $149.9M | $6.4M | $31.0M | $211.2M | $74.9M | $101.2M | ||||||||||||||||
| Paid In Kind Interest | $415.0K | $383.0K | $257.0K | $0.00 | $63.0K |
Most recent annual filing with the SEC: May 22, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.